SEC Form 4 · accession 0000904454-15-000142
GENOCEA BIOSCIENCES, INC. · GNCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J Higgins
Director
Period of report
Feb 26, 2015
Accepted (ET)
Feb 27, 2015 · 1:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001457612
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $9.08 | Feb 26, 2015 | A | 10,084 | A | — | Feb 25, 2025 | Common Stock | 10,084 | 10,084 | D |
Explanation of responses
- F1The option vests annually in equal installments over a three-year period beginning on the date of grant.